You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Hands-Free Human Machine Interfaces for Clinical Healthcare Providers Using Intelligent Agents

    SBC: Ejenta, Inc.            Topic: DHP163001

    The objective of project is to develop a solution that allows doctors, nurses, medics and other healthcare providers to interact with the Electronic Health Record (EHR) in a hands-free manner, while keeping hands completely free to work with patients. Tod

    SBIR Phase I 2017 Department of DefenseDefense Health Agency
  2. Educational Medical Simulation and Training Augmented-Reality Tool

    SBC: Physical Optics Corporation            Topic: DHP163002

    To address the DHP and USAMRMC need for a system to augment a dynamic 3D scene registration using augmented reality (AR) to provide anatomically accurate registration and overlays to aid in medical training, Physical Optics Corporation (POC) proposes to develop a new Educational Medical Simulation and Training Augmented-Reality (EMSTAR) tool. The tool is based on the unique combination of low-cost ...

    SBIR Phase I 2017 Department of DefenseDefense Health Agency
  3. Innovative Multi-Mode Vapor Thermal Desorption Devices

    SBC: SEACOAST SCIENCE, INC.            Topic: DHA17006

    The US Centers for Disease Control and Prevention (CDC) estimate that, on average, approximately 15,000 workers each year in the U.S. suffer respiratory diseases caused by toxic agents in the air. As engineered materials become more dominant in construction of homes, offices and industrial buildings, the potential increases for deleterious solvent, plasticizer, and adhesive vapors infiltrating th ...

    SBIR Phase I 2017 Department of DefenseDefense Health Agency
  4. Development of Thermal Desorption (TD) Tube Sequential Sampler

    SBC: TOYON RESEARCH CORPORATION            Topic: DHA17006

    Toyon Research proposes to develop a Thermal Desorption tube sampling system, capable of meeting the requirements stated in the project solicitation: a programmable interface that allows adjusting sampling system operation in situ; a mechanical design that supports replacing used tubes to support indefinite sampling periods; and an approach for receiving trigger signals from a real-time sensor. Ba ...

    SBIR Phase I 2017 Department of DefenseDefense Health Agency
  5. Conformable Orthopaedic Repair Approach

    SBC: Physical Optics Corporation            Topic: DHA17009

    To address the DHA need for a new treatment approach for osteochondral defects that is able to conform to a wide range of complex geometries, Physical Optics Corporation (POC) proposes to develop a new Conformable Orthopaedic Repair Approach (CORA). It is based on minimally invasive delivery of a gel that can be stabilized in situ at the defect site. Specifically, the innovation in our approach is ...

    SBIR Phase I 2017 Department of DefenseDefense Health Agency
  6. Diagnostic device for detecting biomarkers of early multiorgan injury in saliva

    SBC: NANOCOMPOSIX, INC.            Topic: DHP16006

    Combat soldiers are exposed to vast numbers of dangerous chemicals with potentially adverse health outcomes. This SBIR proposal aims to develop a new class of saliva based diagnostic assays that will measure the bodys response to toxic chemical exposure with a panel of clinically validated biomarkers that are indicative of organ injury. The tests will leverage the proven functionality of lateral ...

    SBIR Phase II 2017 Department of DefenseDefense Health Agency
  7. A New Class of Non-Opioid Analgesics for Use in Chronic Pain Management

    SBC: Kalyra Pharmaceuticals, Inc.            Topic: NonDOD

    There has been considerable interest in the development of alternative therapies for pain management that are neither opioid nor non-steroidal anti-inflammatory drugs (NSAIDs). Kalyra Pharmaceuticals has demonstrated that acetaminophen, also known as APAP

    SBIR Phase II 2017 Department of DefenseDefense Health Agency
  8. Novel Super-cooling of Genitourinary Cells and Tissues for Transplant

    SBC: X-Therma Inc.            Topic: DHP16012

    A key bottleneck to be addressed in regenerative medicine is hypothermic preservation of cells and tissues, which has been shown to extend survival of cell and tissue-based therapies by decreasing ischemic effect. However, preservation technology is aged, toxic and less effective than desired with typical cell survival post-thaw below 50% and unreliable potency. Current technology greatly hinders ...

    SBIR Phase II 2017 Department of DefenseDefense Health Agency
  9. Humeral Head Intraosseous Training System

    SBC: Strategic Operations, Inc.            Topic: DHP13001

    Strategic Operations is noted for its rapid prototyping, manufacturing, distribution, and training capabilities; while Vcom3D is a leader in developing and fielding highly effective game-based learning products. The transition from R&D to manufacturing the Blended VR/Manikin Humeral Head IO Trainer for the Army and other military service use and commercialization to the civilian market will be se ...

    SBIR Phase II 2017 Department of DefenseDefense Health Agency
  10. Selective Aortic Arch Perfusion Technologies for Hemorrhage-induced Cardiac Arrest

    SBC: RESUSITECH, INC.            Topic: DHP16009

    Trauma is the most common cause of death in ages 1-48. Uncontrolled hemorrhage in the torso is the leading cause of preventable death in military combatants and civilian trauma patients with otherwise survivable injuries. The prospects for survival from hemorrhage-induced traumatic cardiac arrest (HiTCA) are dismal with only about a 1% survival rate. Advances in endovascular technologies have led ...

    SBIR Phase II 2017 Department of DefenseDefense Health Agency
US Flag An Official Website of the United States Government